Sign in to view content

The Effect of Intravitreal Afilbercept on Perfusion Status in Patients with Retinal Vascular Disease

Jeffrey S. Heier, MD

Video
Published 2016

Related

The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses
David S. Boyer, MD
Annual Meeting Talks
2019
FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Ivan J. Suner, MD, MBA
Annual Meeting Talks
2019
Trends in the treatment of proliferative diabetic retinopathy before and after the Diabetic Retinopathy Clinical Research Network Protocol S study
John W Hinkle, MD
Updates from the Field
2020

Category: Retinal Vascular Disease

See more